It seems therefore that infection, and not parenteral vaccination, is necessary to trigger a robust tissue-localized SARS-CoV-2-specific T cell response, a notion that is also in line with the different phenotypes of circulating Spike-specific T cells observed in vaccinated naïve or convalescent individuals [67]. Here, CHMP5 is linked to infection.